Position in NVS
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$1,740,062
+$15,209 QoQ
Shares Held
11,103
-1.7% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#467
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Brookstone Capital Management holds $235,547,820 across 12 Drug Manufacturers - General names. NVS ranks #10 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
65,395 | $78,436,731 | |
| 2 | JNJ |
Johnson & Johnson
|
184,287 | $46,803,369 | |
| 3 | AMGN |
Amgen Inc
|
97,295 | $35,232,465 | |
| 4 | ABBV |
AbbVie Inc.
|
91,033 | $22,907,544 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
144,784 | $18,292,010 | |
| 6 | MRK |
Merck & Co., Inc.
|
130,290 | $16,742,265 | |
| 7 | PFE |
Pfizer Inc
|
272,912 | $6,571,720 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
94,227 | $5,429,359 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,740,062 | 11,103 | Shares | Sole | 2026-07-15 | |
| 2026-03-31 | $1,724,853 | 11,292 | Shares | Sole | 2026-04-16 | |
| 2025-12-31 | $1,667,813 | 12,097 | Shares | Sole | 2026-01-15 | |
| 2025-09-30 | $1,552,601 | 12,107 | Shares | Sole | 2025-10-15 | |
| 2025-06-30 | $1,390,041 | 11,487 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $1,351,917 | 12,127 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $1,158,475 | 11,905 | Shares | Sole | 2025-01-13 | |
| 2024-09-30 | $1,354,360 | 11,775 | Shares | Sole | 2024-10-08 | |
| 2024-06-30 | $1,269,003 | 11,920 | Shares | Sole | 2024-07-18 | |
| 2024-03-31 | $1,241,336 | 12,833 | Shares | Sole | 2024-04-15 | |
| 2023-12-31 | $1,279,390 | 12,671 | Shares | Sole | 2024-01-11 | |
| 2023-09-30 | $1,220,995 | 11,987 | Shares | Sole | 2023-10-20 | |
| 2023-06-30 | $1,193,765 | 11,830 | Shares | Sole | 2023-07-11 | |
| 2023-03-31 | $1,585,988 | 17,239 | Shares | Sole | 2023-04-19 | |
| 2022-12-31 | $1,660,448 | 18,303 | Shares | Sole | 2023-01-09 | |
| 2022-09-30 | $1,396,227 | 18,369 | Shares | Sole | 2022-10-14 | |
| 2022-06-30 | $1,561,015 | 18,467 | Shares | Sole | 2022-07-11 | |
| 2022-03-31 | $1,005,088 | 11,454 | Shares | Sole | 2022-04-12 | |
| 2021-12-31 | $1,044,654 | 11,943 | Shares | Sole | 2022-01-11 | |
| 2021-09-30 | $851,820 | 10,416 | Shares | Sole | 2021-11-03 | |
| 2021-06-30 | $928,275 | 10,174 | Shares | Sole | 2021-07-14 | |
| 2021-03-31 | $690,934 | 8,083 | Shares | Sole | 2021-04-16 | |
| 2020-12-31 | $752,229 | 7,966 | Shares | Sole | 2021-01-13 | |
| 2020-09-30 | $699,941 | 8,049 | Shares | Sole | 2020-10-13 | |
| 2020-06-30 | $743,088 | 8,508 | Shares | Sole | 2020-07-21 | |
| 2020-03-31 | $225,088 | 2,730 | Shares | Sole | 2020-04-14 | |
| No filing history on record for this holder in this stock. | ||||||